Edwards Lifesciences Refocuses On Core TAVR And Mitral Growth Story [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
Edwards Lifesciences (NYSE:EW) is ending its planned acquisition of JenaValve. The company is redirecting the capital that would have gone to the deal into its internal transcatheter aortic valve replacement (TAVR) and mitral valve programs. This move reflects a shift toward developing in house platforms instead of expanding through this external transaction. Edwards Lifesciences is a major player in structural heart therapies, with TAVR and mitral valve technologies at the center of its portfolio. The decision to step away from the JenaValve acquisition and focus on internal platforms keeps attention on areas where Edwards already has deep expertise and existing product lines. For investors, it is a capital allocation signal tied directly to the company's core specialties. By concentrating resources on its own TAVR and mitral programs, Edwards is focusing on clinical and technological capabilities it already controls. For you as an investor, the key questions now are how thi
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Should Weakness in Edwards Lifesciences Corporation's (NYSE:EW) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care ConferenceBusiness Wire
- Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences (NYSE:EW) was given a new $110.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
EW
Earnings
- 10/30/25 - Beat
EW
Sec Filings
- 1/12/26 - Form 8-K
- 1/9/26 - Form 4
- 1/6/26 - Form 4
- EW's page on the SEC website